메뉴 건너뛰기




Volumn 123, Issue 13, 2011, Pages

Letter by uretsky regarding article, outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

EID: 79954452357     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.977751     Document Type: Letter
Times cited : (1)

References (2)
  • 1
    • 77954082878 scopus 로고    scopus 로고
    • Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial
    • Morice M-C, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DR, Torracca L, Van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645-2653.
    • (2010) Circulation , vol.121 , pp. 2645-2653
    • Morice, M.-C.1    Serruys, P.W.2    Kappetein, A.P.3    Feldman, T.E.4    Stahle, E.5    Colombo, A.6    MacK, M.J.7    Holmes, D.R.8    Torracca, L.9    Van Es, G.A.10    Leadley, K.11    Dawkins, K.D.12    Mohr, F.13


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.